Literature DB >> 7360526

Rapidly progressive glomerulonephritis in children: a report of thirteen cases and a review of the literature.

R J Cunningham, M Gilfoil, T Cavallo, B H Brouhard, L B Travis, M Berger, T Petrusick.   

Abstract

The clinical course and outcome of rapidly progressive glomerulonephritis (RPGN) of variable etiology are not well defined in children. The present investigation reports on the clinical characteristics, the course and outcome, as well as the results of treatment of 13 children with apparent postinfectious RPGN. Three of 7 patients with documented streptococcal RPGN and 3 of 6 patients with RPGN of nonstreptococcal etiology progressed to chronic renal failure. In some patients, anticoagulant and antiplatelet therapy appear to have improved survival. The severity of crescent formation, not the presumable etiology, appears to be a reliable prognosticator.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7360526     DOI: 10.1203/00006450-198002000-00012

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  4 in total

1.  Crescentic glomerulonephritis in children.

Authors:  H M Jardim; J Leake; R A Risdon; T M Barratt; M J Dillon
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

2.  Clinical spectrum and outcome of crescentic glomerulonephritis in children in developing countries.

Authors:  Deepak Dewan; Sanjeev Gulati; Raj K Sharma; Narayan Prasad; Manoj Jain; Amit Gupta; Alok Kumar
Journal:  Pediatr Nephrol       Date:  2007-12-11       Impact factor: 3.714

Review 3.  The treatment of glomerulonephritis in children.

Authors:  G B Haycock
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

4.  Post-infectious glomerulonephritis with crescents in adults: a retrospective study.

Authors:  Shashidhar Baikunje; Mahesha Vankalakunti; A Nikith; A Srivatsa; Suhan Alva; Janardhan Kamath
Journal:  Clin Kidney J       Date:  2016-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.